Factor VII deficiency

British Journal of Haematology

Volumn 118, Issue 3, 2002, Pages 689-700

  Perry, David J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Assays; Bleeding diathesis; Factor VII; Mutations; Treatment

Indexed keywords

ACENOCOUMAROL; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; CEPHALOSPORIN; DICOUMAROL; FIBRIN GLUE; FIBRINOGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; PENICILLIN G; PHENINDIONE; PHENPROCOUMON; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SINTHROMIN; TRANEXAMIC ACID; VITAMIN K GROUP; WARFARIN;

BLEEDING DISORDER; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD VESSEL INJURY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MAPPING; GENETIC DISORDER; HUMAN; LIVER DISEASE; MORBIDITY; MORTALITY; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTHROMBIN TIME; REGULATORY MECHANISM; REVIEW; THROMBOSIS; VITAMIN K DEFICIENCY;

ANIMALS; BLOOD COAGULATION; FACTOR VII; FACTOR VII DEFICIENCY; HUMANS; MICE; MUTATION; THROMBOSIS;

EID: 0036040213     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03545.x     Document Type: Review

References (102)

1. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter
2. Treatment of factor VII deficiency with recombinant factor VIIa
3. Homocystinuria. A type with vascular thrombosis and factor VII deficiency
4. Isolation and expression of cDNAs encoding human factor VII
5. Molecular analysis of factor VII deficiency in Italy: A frequent mutation (FVII Lazio) in a repeated intronic region
6. Molecular defects in CRM+ factor VII deficiencies: Modelling of missense mutations in the catalytic domain of FVII
7. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma
8. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations
9. Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced Child's B & C cirrhosis
10. Hypoprothrombinemia associated with interleukin-2 therapy: Correction with vitamin K
11. Acquired isolated factor VII deficiency during sepsis
12. An enzyme immunoassay (ELISA) for the quantitation of human factor VII
13. Hip surgery in a patient with severe factor VII deficiency
14. Kinetics of human factor VII activation
15. A new mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency
16. Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: A summary of case reports
17. Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein
18. A factor VII concentrate for therapeutic use
19. Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency
20. Peri-operative replacement therapy with factor VII concentrate in a patient with severe factor VII deficiency
21. Successful treatment of hemorrhagic syndrome due to an acquired, combined deficiency of factors VII and X in a patient with multiple myeloma and amyloidosis
22. Severe arterial thrombosis in a congenitally factor VII deficient patient
23. Cardiac surgery with extracorporeal circulation in severe factor VII deficiency
24. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa
25. Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with anti-thymocyte globulin and high-dose methylprednisolone
26. Open heart surgery with factor VII deficiency
27. Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency
28. Factor VII Padua: A congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern
29. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals
30. Surgery for scoliosis in congenital factor VII deficiency
31. Thrombophilia and lipid profile in post-menopausal women using a new transdermal oestradiol patch
32. Factor VII gene polymorphisms, factor VIIC levels and features of insulin resistance in non-insulin-dependent diabetes mellitus
33. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity
34. The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies
35. Use of recombinant factor VIIa in surgery in factor VII deficient patients
36. Initiation of the tissue factor pathway of coagulation in the presence of heparin: Control by antithrombin III and tissue factor pathway inhibitor
37. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency
38. Hypoprothrombinemia and hemorrhage in a surgical patient treated with cefotetan
39. Purification and characterization of factor VII inhibitor found in a patient with life threatening bleeding
40. Superior sagittal sinus thrombosis with homocystinuria and deficiency of antithrombin III and factor VII: Case report
41. Selection of replacement therapy for patients with severe factor VII deficiency
42. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms - The Leiden Thrombophilia Study (LETS)
43. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa
44. Intronexon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: The factor Xa dependent inhibitor of the extrinsic pathway of coagulation
45. Clinical experience with recombinant factor VIIa
46. Exclusion of the first EGF domain of factor VII by a splice site mutation causes lethal factor VII deficiency
47. The management of coumarin-induced over-anticoagulation
48. Coagulation defects in liver disease
49. PCR detection of a repeat polymorphism within the F7 gene
50. Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7)
51. A missense mutation (178Cys ->Tyr) and two neutral dimorphisms (115His and 333Ser) in the human coagulation factor VII gene
52. Treatment of congenital factor VII deficiency with a new concentrate
53. Factor VII congenital deficiency. Clinical picture and classification of the variants
54. Molecular and clinical aspects of factor VII deficiency
55. Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies
56. Risks and mechanisms of cardiovascular events in users of oral contraceptives
57. Haemostasis function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
58. Factor VII inhibitor
59. Liver-specific expression of the gene coding for human factor X, a blood coagulation factor
60. Plasma factor VIIa: Measurement and potential clinical significance
61. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
62. Diet-responsive proconvertin (factor VII) deficiency in homocystinuria
63. Gastrectomy for a patient with congenital factor VII deficiency - A case report
64. Lupus anticoagulant associated with specific inhibition of factor VII in a patient with AIDS
65. Deletion of the membrane anchoring region of tissue factor abolishes auto-activation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity
66. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation
67. Lowered antithrombin III activity and other clotting changes in homocystinuria: Effects of a pyridoxine-folate regimen
68. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency
69. A novel polymorphism in intron 1a of the human factor VII gene (G73A): Study of a healthy Italian population and of 190 young survivors of myocardial infarction
70. Homozygous 2bp deletion in the human factor VII gene: A non-lethal mutation that is associated with a complete absence of circulating factor VII
71. Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency
72. A novel specific immunoassay for plasma two-chain factor VIIa: Investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes
73. Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies
74. Factor VII clotting assays: Influence of different thromboplastins and factor VII deficient plasmas
75. Functional characterization of the human factor VII 5′-flanking region
76. Acquired factor VII deficiency associated with pleural liposarcoma
77. Clinical study of recovery and half-life of vapor-heated factor VII concentrate
78. Inherited disorders of prothrombin conversion
79. Hereditary factor VII deficiency in pregnancy: Peripartum treatment with factor VII concentrate
80. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding
81. Practical approaches for surgical procedures in congenital factor VII deficiency
82. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency
83. Gastrectomy in congenital factor VII deficiency with substitution of factor VII concentrate
84. Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group
85. Thrombotic complications after substitution with a FVII concentrate
86. Hypertriglyceridaemia and hypercoagulability
87. Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors
88. Multiple extractions in a patient with factor VII deficiency
89. Pharmacokinetics of recombinant factor VIIa in the rat - A comparison of bio-, immuno- and isotope assays
90. Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assay
91. Hereditary factor VII deficiency and increased contact activation time
92. Hereditary factor VII deficiency: Heterogeneity defined by combined functional and immunochemical analysis
93. Acquired factor VII deficiency associated with aplastic anaemia: Correction with bone marrow transplantation
94. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency
95. Prothrombin complex concentrates: Preparation, properties, and clinical uses
96. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells
97. Measurement of basal levels of factor VIIa in hemophilia A and B patients
98. The role of phospholipids and the factor VII Gla-domain in the interaction of factor VII with tissue factor
99. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency
100. Twenty two novel mutations of the factor VII gene in factor VII deficiency
101. Congenital factor VII deficiency. A report of four new cases